ERA-EDTA Operative Headquarters
Via XXIV Maggio 38
43123 Parma – Italy
Phone: +39 0521 989078
Fax: +39 0521 959242
E-mail: secretariat@era-edta.org
ERA-EDTA Registered Office
c/o PKF Littlejohn, 15 Westferry Circus, Canary Wharf
London E14 4HD – United Kingdom
.av-share-box ul li{
display: none!important;
}
Plasma exchange in the pediatric population
News, News-HomeTherapeutic plasma exchange (TPE) is performed in a wide range of hematologic, neurologic, rheumatologic, renal and conditions related to organ transplantation. However, indications and outcomes are still mostly based on adult studies and evidence-based data are still lacking for the pediatric population which can also benefit from this procedure in specific circumstances. Research by Guntulu […]
New hope for patients with primary hyperoxaluria type 1
News, News-HomeLumasiran is an investigational RNAi therapeutic that inhibits oxalate production by targeting hydroxyacid oxidase 1, which depletes glycolate oxidase. The latest results from the phase 3 ILLUMINATE-A trial suggest that lumasiran effectively reduces urinary oxalate excretion at 6 months in patients with type 1 primary hyperoxaluria. Furthermore, it was well tolerated and was not associated […]
Valsartan combined with vitamin D more efficiently reduces moderate proteinuria in IgA nephropathy
News, News-HomeIgA nephropathy is a leading causes of chronic renal disease and end stage renal disease (ESRD). The risk of progression to ESRD is associated with the level of proteinuria, thus underlining the importance of adequate proteinuria control. A prospective, single-center, randomized controlled study followed patients with IgA nephropathy and moderate proteinuria of 1.0–3.0 g/24 h receiving valsartan, […]
Results from the PDOPPS on peritoneal dialysis related infection are available
News, News-HomePeritonitis is still a major concern for peritoneal dialysis (PD) patients and caregivers. The latest Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) reports the results from an observational prospective cohort investigation of 7,051 adult PD patients from seven countries. The crude peritonitis rate was 0.28 episodes per patient-year, ranging from 0.26 in the United […]
A new approach to the treatment of uremic itch
News, News-HomeUremic pruritus remains an important issue in haemodiaysis patients. It has a high prevalence and is often associated with poor sleep quality, psychological disturbances, risk of infections and even death. Several interventions have been attempted with limited success thus far. Difelikefalin, a peripherally restricted and selective agonist of kappa opioid receptors might be a promising […]
New GlomCon/ERA-EDTA Webinar on “microRNA: From Physiology to Disease – Applications in Nephrology”!
News, News-HomeThe new GlomCon/ERA-EDTA roundtable discussion is scheduled today, January 14,2020 at 4 pm CET, 5 pm GMT and 8 am PST. Dr Anastasiia Rind will discuss on “microRNA: From Physiology to Disease – Applications in Nephrology” with Dr Kate Stevens and Dr Laura Denby.
Number of people in need of renal replacement therapy is rising
News, News-HomeThe 2017 Annual Report of the ERA-EDTA Registry reveals that only a small fraction of patients accepted for renal replacement therapy are able to start this treatment with the best available therapy, which is transplantation, and that the number of people who are in need of renal replacement therapy is rising. This poses a major […]
Exercise as ERBP guideline topic
News, News-HomeThis year, European Renal Best Practice (ERBP), the official guideline body of ERA-EDTA, launched its first open call to explore, understand and evaluate topics that are essential to our most important stakeholders. The submitted topics were critically appraised using a validated methodology for Priority Determination of Topics and the ERBP Advisory Board is pleased to […]
NDT Digest on CKD of undetermined aetiology
News, News-HomeCKD of undetermined aetiology leads to premature loss of life at an unprecedented scale in agricultural communities in low- and middle-income countries. Such a burden of disease is unlikely to have been neglected for so long had it been occurring in high-income settings. As the cause remains unclear, only methodologically robust studies, conducted in partnership […]
Effects of a novel medium cut-off dialyser on haemodialysis patients
News, News-HomeNovel medium cut-off (MCO) membrane or ‘expanded haemodialysis’ provides diffusive removal of conventional and large middle molecular weight uraemic toxins, with marginal albumin leak. Despite significant advances in haemodialysis (HD) in recent decades, current dialysis techniques are limited by inadequate removal of uraemic solutes such as middle molecules and protein-bound uraemic toxins. Novel medium cut-off […]